BR0108951A - Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama - Google Patents

Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama

Info

Publication number
BR0108951A
BR0108951A BR0108951-0A BR0108951A BR0108951A BR 0108951 A BR0108951 A BR 0108951A BR 0108951 A BR0108951 A BR 0108951A BR 0108951 A BR0108951 A BR 0108951A
Authority
BR
Brazil
Prior art keywords
exemestane
breast cancer
line treatment
treatment
line
Prior art date
Application number
BR0108951-0A
Other languages
English (en)
Inventor
Giorgio Massimini
Robert Paridaens
Jean-Pierre Lobelle
Gabriela Piscitelli
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BR0108951A publication Critical patent/BR0108951A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"USO DE EXEMESTANO, E MéTODO PARA O TRATAMENTO DE PRIMEIRA LINHA DE C NCER DE MAMA". é revelado exemestano para uso no tratamento de primeira linha de câncer de mama metastático, avançado, dependente de hormónio, particularmente em mulher pós-menopausa.
BR0108951-0A 2000-03-03 2001-02-20 Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama BR0108951A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0005257.1A GB0005257D0 (en) 2000-03-03 2000-03-03 Breast cancer hormonal therapy
PCT/EP2001/001883 WO2001064193A2 (en) 2000-03-03 2001-02-20 Exemestane for first-line treatment of breast cancer

Publications (1)

Publication Number Publication Date
BR0108951A true BR0108951A (pt) 2002-11-26

Family

ID=9886975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108951-0A BR0108951A (pt) 2000-03-03 2001-02-20 Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama

Country Status (22)

Country Link
US (1) US20030144259A1 (pt)
EP (1) EP1530478A2 (pt)
JP (1) JP2003525233A (pt)
KR (1) KR20020084167A (pt)
CN (1) CN1213755C (pt)
AU (1) AU2001254652A1 (pt)
BR (1) BR0108951A (pt)
CA (1) CA2401041A1 (pt)
CZ (1) CZ20022981A3 (pt)
EA (1) EA005413B1 (pt)
EE (1) EE200200479A (pt)
GB (1) GB0005257D0 (pt)
HK (1) HK1053424A1 (pt)
HR (1) HRP20020716A2 (pt)
HU (1) HUP0301123A3 (pt)
MX (1) MXPA02008574A (pt)
NO (1) NO20023971D0 (pt)
NZ (1) NZ521315A (pt)
PL (1) PL358542A1 (pt)
SK (1) SK11902002A3 (pt)
WO (1) WO2001064193A2 (pt)
ZA (1) ZA200207260B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040024044A1 (en) * 2000-09-08 2004-02-05 Di Salle Enrico Exemestane as chemopreventing agent
EP2269603B1 (en) 2001-02-19 2015-05-20 Novartis AG Treatment of breast tumors with a rapamycin derivative in combination with exemestane
PT1624878E (pt) * 2003-05-22 2007-01-31 Pantarhei Bioscience Bv Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
KR200450538Y1 (ko) * 2008-05-29 2010-10-11 최용희 보자기형배낭
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
HK1053424A1 (en) 2003-10-24
NO20023971L (no) 2002-08-21
HUP0301123A3 (en) 2007-10-29
EE200200479A (et) 2003-12-15
CZ20022981A3 (cs) 2003-02-12
CN1407896A (zh) 2003-04-02
CN1213755C (zh) 2005-08-10
WO2001064193A3 (en) 2002-07-25
US20030144259A1 (en) 2003-07-31
PL358542A1 (en) 2004-08-09
JP2003525233A (ja) 2003-08-26
SK11902002A3 (sk) 2003-05-02
NO20023971D0 (no) 2002-08-21
GB0005257D0 (en) 2000-04-26
EA200200943A1 (ru) 2003-02-27
EP1530478A2 (en) 2005-05-18
AU2001254652A1 (en) 2001-09-12
HRP20020716A2 (en) 2003-12-31
KR20020084167A (ko) 2002-11-04
ZA200207260B (en) 2003-09-10
WO2001064193A2 (en) 2001-09-07
CA2401041A1 (en) 2001-09-07
EA005413B1 (ru) 2005-02-24
MXPA02008574A (es) 2003-05-01
NZ521315A (en) 2008-10-31
HUP0301123A2 (hu) 2003-08-28

Similar Documents

Publication Publication Date Title
SI1556058T1 (sl) Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
EP1090291A4 (en) PROCESS FOR EARLY DIAGNOSIS AND FORECAST OF CANCER
BR0108951A (pt) Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama
SG148031A1 (en) Use of cci-779 as an antineoplastic agent
GB9818916D0 (en) Use
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
GB9718745D0 (en) Improvements in or relating to screening for carcinoma
WO2002058706A3 (en) Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
AU4347701A (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
IT1290908B1 (it) Agente ausiliario di macinazione per cemento.
HK1040983A1 (en) Quinones for treatment of diseases.
BR0108728A (pt) Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
ITMI20000249A0 (it) Citochine modificate per uso nella terapia del cancro
WO2002072021A3 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
HK1043997A1 (en) Chalcone coumarins
AU6228000A (en) The use of retinoid receptor antagonists in the treatment of prostate carcinoma
BR0109789A (pt) Método para o tratamento de câncer de mama, e, uso de fulvestrante
IS5502A (is) Samtengd efnasambönd nytsamleg við meðhöndlun á krabbameini í blöðruhálskirtli
BR0214798A (pt) Uso de anastrozol ou um sal farmaceuticamente aceitável do mesmo, e, métodos para reduzir a taxa de recorrência de câncer e a taxa de um novo tumor primário contralateral em uma mulher pós-menopausa tendo câncer de mama em estado inicial
IT1320044B1 (it) Trattamento superficiale per inserto in carburo di tungsteno.
BR0013272B1 (pt) Uso de um inibidor de aromatase esteroidal
AU2342299A (en) Compositions and methods for detecting and treating breast cancer
ZA200104565B (en) Methods and devices for use in installation of underwear conduits.
PE20020511A1 (es) Uso de antiprogestinas para la induccion de apoptosis en una celula
ES1041639Y (es) Conjunto para aplicacion de motivos graficos en el cabello.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009